Dongkwang pharmaceuticals
- Biotech or pharma, therapeutic R&D
Dongkwang Pharmaceutical is a 70-year-old leading Korean company in the osteoarthritis treatment market, operating two manufacturing plants and a nationwide sales team of 500.
With 2024 sales of approximately USD 200 million and annual growth near 10%, Dongkwang is strengthening its core portfolio while expanding into new therapeutic areas like dermatology through innovative products.
Address
SeoulSouth Korea
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}